Ama-anti-depressants yizona ezivame ukubeka izidakamizwa ze- fibromyalgia nesifo esingapheli syndrome , kodwa leli klasi lezidakamizwa linengozi enkulu yemiphumela emibi, kanti uhlu lwemiphumela emibi lwenzeka isikhathi eside.
Isidakamizwa esibizwa ngokuthi i-Viibryd (i-vilazodone) sithembisa ukuhlinzeka ngokukhululeka ngemiphumela emibi embalwa, futhi ukuhlolwa kwemitholampilo kusikisela ukuthi kuncane amathuba okubangela ukutholakala kwesisindo kanye nemiphumela emibi yocansi okuvame ukuholela abantu ukuba baye kwezinye izidakamizwa zokucindezeleka.
Viibrid Different kanjani?
I-Viibrid uhlobo lwe-anti-depressant olubizwa ngokuthi i-SSRI (i-serotonin e-reuptake inhibitor ekhethiwe). Kodwa i-Viibrid ihlukile ngoba ihlose ngaphezu kokuphindwa kabusha.
I-reuptake isisekelo sokugcina indlu yobuchopho. Uma i-neuron eyodwa (ubuchopho beselula) ithumela umlayezo komunye, yenza kanjalo ngamakhemikhali abizwa ngokuthi ama-neurotransmitters , futhi i- serotonin ibaluleke kakhulu kithi, njengoba ngokuvamile singenayo ngokwanele noma singayisebenzisi kahle.
Uma une-serotonin ephansi (noma i-neurotransmitter), umlayezo othunyelwe usebenzisa awunawo amandla anele okuthola kusuka ku-neuron eyodwa kuya kwesinye. Kunjengokukhonza kwe-tennis okubuthakathaka kakhulu ukuthola ibhola kunetha. Umfana webhola ogijima ukuqoqa lezi bhola ezingakaze zamukelwe wenza umsebenzi wokuvuselela kabusha-ukuqeda i-serotonin esetshenzisiwe ngakho-ke akusihlanganisi izinto.
Izidakamizwa eziphuthumayo zokugcina i-reuptake zigcina leyo mfana webhola (ngempela ama- glial cells ne-neonons presynaptic) ekuqothuleni i-neurotransmitter futhi izinike isikhathi esengeziwe sokuthumela umyalezo wayo.
Kuze kube manje, sibheke uhlangothi olulodwa lwenkantolo ye-tennis. Kuthiwani ngomfana owela kunetha, i-neuron eyamukela umlayezo? Lelo seli linemitholampilo, futhi i-receptor ngayinye iklanyelwe ukwamukela kuphela imilayezo evela kwezinye izinzwa ze-neurotransmitters. Ngokuyinhloko, i-receptor ikhiyiwe, futhi kuphela izikhiye zamakhemikhali ezilungile ezingayivula.
I-Viibryd ihlose ama-receptors athile we-serotonin anezihluthulelo ezifanisiwe futhi ayibangele ekuvulekeni, okwenza kube lula ukuthi imiyalezo igeleza kusuka kuseli kuya esitokisini.
Lokho esikubonayo ukuthi njengoba izidakamizwa ziba ezikhethekile kakhulu ngale ndlela, ziyaqhubeka ziphumelela ngemiphumela emibi embalwa. Ngokuzama ukungena ezindleleni ezithile nezindlela ezilinganiselwe zobuchopho obusebenzayo, zingabheka kangcono inkinga engaphansi kunokushintsha isimo sezindawo ezinkulu zobuchopho ezilawula izinto esingafuni ukuzidlela nazo.
Izifundo
Kuze kube manje, i-Viibrid ayizange ifundwe nhlobo ngenxa ye-fibromyalgia noma isifo esingapheliyo sokukhathala.
Izifundo, kubandakanya ezinye ezinkulu, zisho ukuthi i-Viibrid iphumelela ngokumelene nokucindezeleka okukhulu kokucindezeleka kanye nokukhathazeka okwenziwe jikelele, okubili kokuvamile kubantu abane-fibromyalgia nesifo esingapheliyo sokukhathala. Ucwaningo lubonisa ukuthi kubekezelelwe kahle.
Ucwaningo olushicilelwe ngo-2017 alutholanga umphumela emsebenzini ozocansi kubantu abadala abanempilo.
Okuqhamuka uma udla imishanguzo
Ngenkathi i-Viibrid ibonakala ibe nemiphumela emibi kakhulu kunezinye izidakamizwa ekilasini layo, lokho akusho ukuthi yilezi zenzalo. (Asikho isidakamizwa.)
Ezilingo, imiphumela emibi ejwayelekile ifakiwe
- isifo sohudo
- isiyaluyalu
- isiyezi
- ukulala
- ama-nightmares / amaphupho angavamile
- ukuhlanza
Uma ucabangela i-Viibryd, qiniseka ukuthi ukhuluma nodokotela wakho kanye nemithi mayelana nezingozi nezinzuzo ezikhona.
Udokotela wakho kanye nomsebenzi wezokwelapha angakusiza ukuthi ubone ukuxhumana okungahambi kahle nezinye izidakamizwa kanye nezithako ozithathayo.
> Imithombo:
> Clayton AH, Durgam S, Li D, et al. Imiphumela ye-vilazodone ekusebenzeni ngokocansi kubantu abadala abanempilo: imiphumela yocwaningo olulawulwa ngokungahleliwe, oluphindwe kabili, oluthile, oluthathwa ngokusebenzayo. I-psychopharmacology yomtholampilo yomhlaba jikelele. 2017 Jan; 32 (1): 27-35.
> Durgam S, Chen C, uGommoll CP, et al. Ukuthuthukiswa kwezigaba ekucindezelweni kwezifo ezigulini ezinezinkinga ezinkulu zokucindezeleka eziphathwe nge-vilazodone: ukuhlaziywa kwe-post hoc kwezilingo ezine ezilawulwe ngokungahleliwe, ezilawulwe nge-placebo. Izifo ze-Neuropsychiatric kanye nokwelapha. 2016 Dec 2; 12: 3073-3081. eCollection 2016.
> Shi L, Wang J, Xu S, Lu Y. Ukusebenza nokubekezela kwe-vilazodone yokucindezeleka okukhulu: ubufakazi obuvela kulesigaba III / IV ukuhlolwa okulawulwa ngokungahleliwe. Ukuklama imithi, ukuthuthukiswa kanye nokwelapha. 2016 Nov 25; 10: 3899-3907. eCollection 2016.